These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 29127443)

  • 21. Celastrol inhibits IL-1β-induced inflammation in orbital fibroblasts through the suppression of NF-κB activity.
    Li H; Yuan Y; Zhang Y; He Q; Xu R; Ge F; Wu C
    Mol Med Rep; 2016 Sep; 14(3):2799-806. PubMed ID: 27484716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polydatin attenuates orbital oxidative stress in Graves' orbitopathy through the NRF2 pathway.
    Li H; Min J; Chen Y; Li H; Zhang Y
    Chem Biol Interact; 2020 Jan; 315():108894. PubMed ID: 31705858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disulfiram Exerts Antiadipogenic, Anti-Inflammatory, and Antifibrotic Therapeutic Effects in an
    Wang X; Yang S; Ye H; Chen J; Shi L; Feng L; Wang X; Zhang T; Chen R; Xiao W; Yang H
    Thyroid; 2022 Mar; 32(3):294-305. PubMed ID: 34605662
    [No Abstract]   [Full Text] [Related]  

  • 24. Astragaloside IV Attenuates Lipopolysaccharides-Induced Pulmonary Epithelial Cell Injury through Inhibiting Autophagy.
    Liu B; Zhao H; Wang Y; Zhang H; Ma Y
    Pharmacology; 2020; 105(1-2):90-101. PubMed ID: 31554002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation of human orbital fibroblasts cultivated from intraconal, nasal and central adipose tissues.
    Kim JA; Ahn D; Kim BY; Choi YJ; Shin HJ; Jang SY
    Br J Ophthalmol; 2021 Feb; 105(2):290-296. PubMed ID: 31488432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sphingosine-1-phosphate is involved in inflammatory reactions in patients with Graves' orbitopathy.
    Seo Y; Chae MK; Han SA; Lee EJ; Lee JH; Yoon JS
    Inflamm Res; 2017 Jun; 66(6):535-545. PubMed ID: 28364200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic effect of selective interleukin-2-inducible tyrosine kinase inhibitor in orbital fibroblasts from patients with Graves' orbitopathy.
    Yoon Y; Park HY; Chae MK; Jang SY; Yoon JS
    Endocr J; 2024 Sep; 71(9):851-861. PubMed ID: 38866492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Astragaloside IV attenuates IL-1β secretion by enhancing autophagy in H1N1 infection.
    Zhang J; Zhang W; Ren L; He Y; Mei Z; Feng J; Shi T; Zhang H; Song Z; Jie Z
    FEMS Microbiol Lett; 2020 Feb; 367(4):. PubMed ID: 32108899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astragaloside IV possesses antiarthritic effect by preventing interleukin 1β-induced joint inflammation and cartilage damage.
    Wang B; Chen MZ
    Arch Pharm Res; 2014 Jun; 37(6):793-802. PubMed ID: 24469603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves' ophthalmopathy.
    Park M; Banga JP; Kim GJ; Kim M; Lew H
    Stem Cell Res Ther; 2019 Aug; 10(1):246. PubMed ID: 31399042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Astragaloside-IV Alleviates Heat-Induced Inflammation by Inhibiting Endoplasmic Reticulum Stress and Autophagy.
    Dong Z; Zhou J; Zhang Y; Chen Y; Yang Z; Huang G; Chen Y; Yuan Z; Peng Y; Cao T
    Cell Physiol Biochem; 2017; 42(2):824-837. PubMed ID: 28641278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of microRNA-146a in regulation of fibrosis in orbital fibroblasts from patients with Graves' orbitopathy.
    Jang SY; Park SJ; Chae MK; Lee JH; Lee EJ; Yoon JS
    Br J Ophthalmol; 2018 Mar; 102(3):407-414. PubMed ID: 29101123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-кB in vivo and in vitro.
    Zhou X; Sun X; Gong X; Yang Y; Chen C; Shan G; Yao Q
    Int Immunopharmacol; 2017 Jan; 42():18-24. PubMed ID: 27855303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.
    Guo Y; Li H; Chen X; Yang H; Guan H; He X; Chen Y; Pokharel S; Xiao H; Li Y
    J Clin Endocrinol Metab; 2020 Jun; 105(6):1906-17. PubMed ID: 32249902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection and modulation of interleukin-1 receptor antagonist messenger ribonucleic acid and immunoreactivity in Graves' orbital fibroblasts.
    Mühlberg T; Heberling HJ; Joba W; Schworm HD; Heufelder AE
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1018-28. PubMed ID: 9112998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EZH2 as a major histone methyltransferase in PDGF-BB-activated orbital fibroblast in the pathogenesis of Graves' ophthalmopathy.
    Visamol S; Palaga T; Saonanon P; Pruksakorn V; Hirankarn N; van Hagen PM; Dik WA; Virakul S
    Sci Rep; 2024 Apr; 14(1):7947. PubMed ID: 38575707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein tyrosine phosphatase 1B as a therapeutic target for Graves' orbitopathy in an in vitro model.
    Byeon HJ; Kim JY; Ko J; Lee EJ; Don K; Yoon JS
    PLoS One; 2020; 15(8):e0237015. PubMed ID: 32760098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential Therapeutic Role of Bone Morphogenic Protein 7 (BMP7) in the Pathogenesis of Graves' Orbitopathy.
    Kim BY; Choi SH; Kim JY; Ko J; Yook JI; Kim HS; Lee EJ; Kikkawa DO; Yoon JS
    Invest Ophthalmol Vis Sci; 2022 Jun; 63(6):7. PubMed ID: 35671049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Adipsin, Complement Factor D, in the Pathogenesis of Graves' Orbitopathy.
    Byeon HJ; Chae MK; Ko J; Lee EJ; Kikkawa DO; Jang SY; Yoon JS
    Invest Ophthalmol Vis Sci; 2023 Aug; 64(11):13. PubMed ID: 37555734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1 receptor antagonist ribonucleic acid and protein expression by cultured Graves' and normal orbital fibroblasts is differentially modulated by dexamethasone and irradiation.
    Mühlberg T; Joba W; Spitzweg C; Schworm HD; Heberling HJ; Heufelder AE
    J Clin Endocrinol Metab; 2000 Feb; 85(2):734-42. PubMed ID: 10690884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.